OR WAIT null SECS
A look at what the Contemporary Pediatrics® team covered this week.
Contemporary Pediatrics® Editorial Advisory Board member Donna Hallas shares her thoughts on the recent authorization of a Pfizer-BioNTech COVID-19 booster shot for children 5-11 years old.
Investigators may have found a piece of the puzzle into what causes sudden infant death syndrome.
This week, the agency announced it is encouraging importation of infant formula from usually unutilized foreign means in hopes of increasing access to the product in the wake of the country-wide shortage.
The proposed aid bill would give the FDA funds to increase staff and prepare for future infant formula shortages.